Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nucleic acid biotechnology.

C M Roth1, M L Yarmush

  • 1Center for Engineering in Medicine and Surgical Services, Massachusetts General Hospital, Harvard Medical School and Shriners Burns Hospital, Boston, Massachusetts 02114, USA. roth@helix.mgh.harvard.edu

Annual Review of Biomedical Engineering
|November 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated end-to-end blood testing at the point-of-care: Integration of robotic phlebotomy with downstream sample processing.

Technology·2018
Same author

Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of <i>in-vitro</i> liver technologies.

Technology·2015
Same author

Polyethylene glycol protects primary hepatocytes during supercooling preservation.

Cryobiology·2015
Same author

Subnormothermic machine perfusion for ex vivo preservation and recovery of the human liver for transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Perfusion defatting at subnormothermic temperatures in steatotic rat livers.

Transplantation proceedings·2013
Same author

Rare-earth-doped biological composites as in vivo shortwave infrared reporters.

Nature communications·2013
Same journal

Physics-Informed Machine Learning in Biomedical Science and Engineering.

Annual review of biomedical engineering·2026
Same journal

Advancements and Challenges in Computer-Assisted Medical Interventions for Image-Guided Prostate Cancer Treatments.

Annual review of biomedical engineering·2026
Same journal

Recent Advances in mRNA Therapeutic Cancer Vaccines.

Annual review of biomedical engineering·2026
Same journal

Artificial Intelligence-Based Analysis of Laparoscopic Imaging for Intraoperative Surgical Decision Support.

Annual review of biomedical engineering·2026
Same journal

Viscoelasticity of the Heart: An Overview of Viscoelastic Measurements at Different Scales.

Annual review of biomedical engineering·2026
Same journal

Digital Twins for Biofluids.

Annual review of biomedical engineering·2026
See all related articles

Emerging nucleic acid technologies like DNA microarrays, antisense technology, and gene therapy offer significant promise for research, diagnostics, and therapeutics. These advancements are poised to impact both laboratory research and clinical practice.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Genomics

Background:

  • Advances in genetic sequencing and nucleic acid manipulation are driving innovation.
  • Nucleic acid-based technologies are increasingly vital for research, diagnostics, and therapeutics.

Purpose of the Study:

  • To review three promising nucleic acid technologies: DNA microarrays, antisense technology, and gene therapy.
  • To provide an overview of their current status, applications, and future challenges.

Main Methods:

  • Review of current scientific literature and technological advancements.
  • Analysis of quantitative and engineering aspects of each technology.

Main Results:

  • DNA microarrays enable high-throughput genetic analysis.

Related Experiment Videos

  • Antisense technology offers targeted gene silencing for therapeutic potential.
  • Gene therapy presents novel approaches for treating genetic disorders.

    • Conclusions:

    • These three nucleic acid technologies hold substantial promise for laboratory and clinical impact.
    • Further advancements require addressing critical issues and engineering challenges.